SCHEMBL24809778

SCHEMBL24809778

CC(C)CNC(=O)n1cnc(C(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 1/20 0.36
HPGD P15428 4/20 0.35
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 3/20 0.34
KMT2A Q03164 2/20 0.33
GAA P10253 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MLYCD O95822 1/20 0.33
CTSL P07711 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 3/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
CNR2 P34972 1/20 0.32
CXCR2 P25025 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24809405 0.80 CTSL (0.36) MLYCDCTSLNPSR1CNR2CXCR2
SCHEMBL24811081 0.79 ASAH1 (0.37) ASAH1HPGDCYP2D6CYP2C19ALDH1A1
SCHEMBL24809456 0.74 MAPK13 (0.48) ASAH1HPGDCYP2D6CYP2C19ALDH1A1
SCHEMBL24810555 0.72 RAB9A (0.52) HPGDALDH1A1KMT2ALMNARAB9A
SCHEMBL24809444 0.71 L3MBTL1 (0.52) HPGDALDH1A1KMT2AGAALMNA
SCHEMBL22951349 0.71 KDM4E (0.35) CTSL
SCHEMBL24810738 0.70 CYP2A6 (0.51) ASAH1CYP2D6CYP2C19CTSL
SCHEMBL24809346 0.70 ASAH1 (0.38) ASAH1HPGDALDH1A1KMT2AGAA
SCHEMBL24810581 0.69 ASAH1 (0.38) ASAH1HPGDCYP2D6CYP2C19ALDH1A1
SCHEMBL29786316 0.68 ASAH1 (0.39) ASAH1HPGDCYP2D6CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL R&D INVEST S A (PT) 2022-12-29 US disclosed
EP-4031531-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 EP disclosed
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411388-A1 SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GAA, CLN6 ASAH1 16/4885HPGD 1683/4885CYP2D6 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.